Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.

By C. Miège, J. Choubert, L. Ribeiro, M. Eusèbe, M. Coquery. Environmental Pollution, 2009

693 citations recorded by the source corpus.

Subfields: Health, Toxicology and Mutagenesis, Molecular Biology, Pollution

View Paper: https://www.semanticscholar.org/paper/39857c456ffdc0181591db55b04e3ebba6cb0c37

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Health, Toxicology and Mutagenesis

1. P. Verlicchi
2. M. A. Aukidy
3. M. Wong
4. Elena Zambello
5. Jin-lin Liu
6. G. Kyzas

In Pollution

1. K. A. Matis
2. P. Verlicchi
3. M. A. Aukidy
4. M. Wong
5. Elena Zambello
6. Jin-lin Liu
7. Jie Fu
8. N. Lazaridis

Citations in the corpus

• Removal of pharmaceuticals and personal care products (PPCPs) from wastewater: A review. (2016, neutral): “The removal efficiency of PPCPs by biological treatment processes has been reviewed previously (Miege et al., 2009; Verlicchi et al., 2012).”
• EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. (2013, result): “This comparison shows that lower median effluent concentrations were found in our large-scale European-wide study (n ¼ 90) compared to local studies of single WWTPs (Miége et al., 2009; Table SI19).”
• Removal of pharmaceuticals and personal care products from wastewater using algae-based technologies: a review (2017, background): “In municipal wastewater influent, concentrations of PPCPs vary considerably from place to place but are generally within the ng L-1 to lg L-1 range (Luo et al. 2014; Miège et al. 2009).”
• Pharmaceuticals and personal care products in the aquatic environment in China: a review. (2013, neutral): “[68].”
• From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: A review. (2017, background): “:3) ege et al., 2009; Deblonde et al., 2011; Verlicchi et al., 2012; Benner et al., 2013; Luo et al., 2014b; Evgenidou et al., 2015, … ), but also groundwaters (Lapworth et al., 2012; Luo et al., 2014b; Sui et al., 2015), surface waters (Luo et al., 2014b), or seawater (Arpin-Pont et al., 2014).”
• New approaches on the removal of pharmaceuticals from wastewaters with adsorbent materials (2015, background): “Moreover, low concentrations can elicit adverse effects on aquatic life [8,9].”
• Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review. (2012, background): “…parent compounds can also undergo further modification due to biological, chemical and physical processes in both sewage treatment facilities and receiving water bodies (Deblonde et al., 2011; Fatta-Kassinos et al., 2011; Miège et al., 2009; Monteiro and Boxall, 2010; Onesios et al., 2009).”
• Pharmaceuticals and personal care products (PPCPs): a review on environmental contamination in China. (2013, background): “Studies in other countries confirmed norfloxacin (the fluoroquinolone) as well as 17β-estradiol and estriol (the steroid estrogens) had removal rates of N80% in STPs (Miège et al., 2009).”